Bariatric Radioembolization: A Pilot Study on Technical Feasibility and Safety in a Porcine Model

J Vasc Interv Radiol. 2016 Oct;27(10):1509-17. doi: 10.1016/j.jvir.2016.05.020. Epub 2016 Aug 1.

Abstract

Purpose: To evaluate feasibility of left gastric artery (LGA) yttrium-90 ((90)Y) radioembolization as potential treatment for obesity in a porcine model.

Materials and methods: This study included 8 young female pigs (12-13 weeks, 21.8-28.1 kg). Six animals received infusions of (90)Y resin microspheres (46.3-105.1 MBq) into the main LGA and the gastric artery arising from the splenic artery. Animal weight and serum ghrelin were measured before treatment and weekly thereafter. Animals were euthanized 69-74 days after treatment, and histologic analyses of mucosal integrity and ghrelin immunoreactive cell density were performed.

Results: Superficial mucosal ulcerations < 3.0 cm(2) were noted in 5 of 6 treated animals. Ghrelin immunoreactive cell density was significantly lower in treated versus untreated animals in the stomach fundus (13.5 vs 34.8, P < .05) and stomach body (11.2 vs 19.8, P < .05). Treated animals gained less weight than untreated animals over the study duration (40.2 kg ± 5.4 vs 54.7 kg ± 6.5, P = .053). Average fundic parietal area (165 cm(2) vs 282 cm(2), P = .067) and average stomach weight (297.2 g vs 397.0 g, P = .067) were decreased in treated versus untreated animals. Trichrome staining revealed significantly more fibrosis in treatment animals compared with control animals (13.0 vs 8.6, P < .05). No significant differences were identified in plasma ghrelin concentrations (P = .24).

Conclusions: LGA (90)Y radioembolization is promising as a potential treatment for obesity. A larger preclinical study is needed to evaluate the safety and efficacy of this procedure further.

Publication types

  • Evaluation Study

MeSH terms

  • Animals
  • Arteries*
  • Biomarkers / blood
  • Embolization, Therapeutic / methods*
  • Feasibility Studies
  • Female
  • Fibrosis
  • Gastric Mucosa / metabolism
  • Ghrelin / blood
  • Infusions, Intra-Arterial
  • Models, Animal
  • Obesity / blood
  • Obesity / physiopathology
  • Obesity / therapy*
  • Pilot Projects
  • Radiopharmaceuticals / administration & dosage*
  • Stomach / blood supply*
  • Stomach / pathology
  • Sus scrofa
  • Time Factors
  • Weight Loss
  • Yttrium Radioisotopes / administration & dosage*

Substances

  • Biomarkers
  • Ghrelin
  • Radiopharmaceuticals
  • Yttrium Radioisotopes